25 results on '"Sashida, Goro"'
Search Results
2. Stem cell regulation and dynamics in myeloid malignancies
3. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
4. ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration
5. The acidic domain of Hmga2 and the domain’s linker region are critical for driving self-renewal of hematopoietic stem cell
6. Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis
7. RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
8. Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation
9. PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome
10. Low prevalence of the BCR–ABL1 fusion gene in a normal population in southern Sarawak
11. Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
12. Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
13. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
14. Deregulated Polycomb functions in myeloproliferative neoplasms
15. Correction to: Systematic review of pre-clinical chronic myeloid leukaemia
16. Systematic review of pre-clinical chronic myeloid leukaemia
17. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
18. Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development
19. Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
20. Epigenetic regulation of hematopoiesis
21. Hepatosplenic 33 T-Cell Lymphoma with Myelodysplastic Syndrome
22. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways
23. Thrombocytopenia Induced by Imatinib Mesylate (Glivec) in Patients with Chronic Myelogenous Leukemia: is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
24. Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
25. Telomeres and telomerase in hematologic neoplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.